Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 64C (TRIM64C) is a poorly characterized, predicted member of the TRIM family of proteins, structurally containing the hallmark tripartite motif: a RING-type zinc finger, a B-box domain, and a coiled-coil region (RBCC motif). As with other TRIM family members, TRIM64C is predicted to function as an E3 ubiquitin ligase, playing a possible role in ubiquitin-dependent protein degradation, innate immune signaling, and the regulation of gene expression. However, there is little or no direct experimental evidence or disease linkage reported specifically for TRIM64C, and its existence as a distinct, functional target is uncertain. Many resources list TRIM64C only as a *predicted* or putative gene/protein, and it is not referenced in key TRIM family reviews or major gene/protein databases as a canonical entity. Its sequence and domain architecture place it within the diversity of the large TRIM C-IV subgroup, which is commonly associated with immune regulation and ubiquitin-mediated processes. Key limitations: - The entity "TRIM64C" does not appear as a well-characterized, widely accepted therapeutic target or a functionally demonstrated protein in the current literature or protein/gene catalogs. - All ascribed functions are *predictions* based on homology, not direct evidence. Summary of issues: - The name and abbreviation "TRIM64C" accurately follow TRIM family nomenclature, but this specific variant is not established as a canonical target. - There is no direct data regarding biomarker roles, drug interaction, safety, or mechanism of action, nor is there verified disease linkage for TRIM64C specifically. - If needing canonical TRIM family information, refer to well-described family members such as TRIM64 or others in the C-IV subgroup. "TRIM64C" likely represents a predicted, not functionally validated, variant or isoform.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 64C (TRIM64C).